GALE Stock Overview
Operates as a healthcare service provider in Switzerland and internationally. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for GALE from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Galenica AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CHF 81.80 |
52 Week High | CHF 86.70 |
52 Week Low | CHF 69.30 |
Beta | 0.29 |
1 Month Change | 5.55% |
3 Month Change | 7.14% |
1 Year Change | 15.78% |
3 Year Change | 12.21% |
5 Year Change | 21.73% |
Change since IPO | 90.23% |
Recent News & Updates
Galenica's (VTX:GALE) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12Here's Why Galenica AG's (VTX:GALE) CEO May Have Their Pay Bumped Up
Apr 04Galenica (VTX:GALE) Will Pay A Larger Dividend Than Last Year At CHF2.30
Mar 20Recent updates
Galenica's (VTX:GALE) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12Here's Why Galenica AG's (VTX:GALE) CEO May Have Their Pay Bumped Up
Apr 04Galenica (VTX:GALE) Will Pay A Larger Dividend Than Last Year At CHF2.30
Mar 20Home Care Expansion And Digital Initiatives Will Drive Future Success
Mar 16 Expansion in home care and pharmacy digitization promises revenue growth and improved market positioning through service integration and enhanced customer engagement.Galenica AG (VTX:GALE) Shares Could Be 50% Below Their Intrinsic Value Estimate
Feb 28Galenica (VTX:GALE) Is Doing The Right Things To Multiply Its Share Price
Dec 28Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing
Nov 12Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Oct 05Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25Shareholder Returns
GALE | CH Healthcare | CH Market | |
---|---|---|---|
7D | -0.4% | -2.4% | -2.9% |
1Y | 15.8% | 14.0% | -2.9% |
Return vs Industry: GALE exceeded the Swiss Healthcare industry which returned 14% over the past year.
Return vs Market: GALE exceeded the Swiss Market which returned -2.9% over the past year.
Price Volatility
GALE volatility | |
---|---|
GALE Average Weekly Movement | 3.4% |
Healthcare Industry Average Movement | 5.2% |
Market Average Movement | 4.6% |
10% most volatile stocks in CH Market | 8.5% |
10% least volatile stocks in CH Market | 2.4% |
Stable Share Price: GALE has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: GALE's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 6,241 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates in two segments: Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers speciality pharmacy mediservice.
Galenica AG Fundamentals Summary
GALE fundamental statistics | |
---|---|
Market cap | CHF 4.08b |
Earnings (TTM) | CHF 183.03m |
Revenue (TTM) | CHF 3.93b |
22.3x
P/E Ratio1.0x
P/S RatioIs GALE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GALE income statement (TTM) | |
---|---|
Revenue | CHF 3.93b |
Cost of Revenue | CHF 3.46b |
Gross Profit | CHF 472.15m |
Other Expenses | CHF 289.12m |
Earnings | CHF 183.03m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Aug 07, 2025
Earnings per share (EPS) | 3.67 |
Gross Margin | 12.01% |
Net Profit Margin | 4.66% |
Debt/Equity Ratio | 36.0% |
How did GALE perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield63%
Payout RatioDoes GALE pay a reliable dividends?
See GALE dividend history and benchmarksGalenica dividend dates | |
---|---|
Ex Dividend Date | Apr 14 2025 |
Dividend Pay Date | Apr 16 2025 |
Days until Ex dividend | 1 day |
Days until Dividend pay date | 3 days |
Does GALE pay a reliable dividends?
See GALE dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/04/13 05:47 |
End of Day Share Price | 2025/04/11 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Galenica AG is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Alexander Berglund | BofA Global Research |
Christoph Gretler | Credit Suisse |
Yi-Dan Wang | Deutsche Bank |